Renal Denervation Devices Market Analysis - Global Industry Size, Share, Trends and Forecast, 2014 - 2024

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC339

Renal denervation is an endovascular catheter based minimally invasive procedure which uses ultrasound ablation or radiofrequency ablation and aims at treating resistant hypertension. The nerves present in the renal artery are ablated by applying ultrasound pulses to the walls of renal arteries causing reduction of sympathetic efferent and afferent activities to the kidneys and thus the blood pressure can be decreased. Earlier, sympathectomy process was deployed for reducing hypertension but had a lot of side effects which were non-selective in nature and were poorly tolerated. Side effects included palpitations, anhydrosis, orthostatic hypotension, loss of ejaculation, intestinal disturbances and atelectasis. Renal denervation procedure involves endovascular access through the femoral artery and often uses catheter mounted device in the walls of renal artery. Generally, a number of albations are applied at different rotational and longitudinal positions to ensure maximum denervation of nerves. Although, the process of renal denervation does not involve any permanent implant. Usually, hypertension is considered as an overactive sympathetic drive and renal denervation stops the cross-talk between brain and kidney through ultrasound and radiofrequency energy waveforms in relatively short bursts along the longitudinal path of major renal arteries to ablate the renal nerves, thus reducing the sympathetic drive.

Currently, the global renal denervation devices market is witnessing significant surge due to increase in prevalence of hypertension among urban population in various developing and developed economies including the U.S., Japan, India, China, Germany, etc. Also, changing lifestyle of people, increasing smoking and drinking habits, increasing inclination towards adoption of preserved foods coupled with lack of physical exercises aids in increasing hypertension and high blood pressure ailments, thus driving the overall global renal denervation devices market. Moreover, increasing investments by governments of various economies for improvement of healthcare infrastructure is another key factor attracting the players to invest in the global renal denervation devices market. Furthermore, cost effectiveness of the overall procedure of renal denervation is another key factor driving the overall growth of global renal denervation devices market. However, renal denervation is a painful procedure as compared to drug based therapies since the ultrasound waves used during the process creates albations in the renal artery thus heating the tissues. Hence, patients are less inclined towards this procedure, thus hampering the overall growth of the global renal denervation devices market. Also, since renal denervation devices are highly specialized devices, the governments of various economies don’t approve such process which is a key factor creating hindrance for the market growth. Although, increasing demand for cost effective therapies alike renal denervation is a key factor posing bright opportunities for the global renal denervation devices market.

The global renal denervation devices market can be segmented on the basis of product type, technology and geography. By product type, the global renal denervation devices market can be segmented into EnligHTN, paradise renal denervation system, simplicity renal denervation system, vessix renal denervation system, iberis renal sympathetic denervation system and others. By technology, the global renal denervation devices market can be segmented into ultrasound, radiofrequency and micro-infusion. On the basis of geography, the global renal denervation devices market can be bifurcated into North America, Europe, Latin America, Middle East & Africa (MEA) and Asia-Pacific.

Major players involved in manufacturing of renal denervation devices are currently focusing on penetrating in emerging economies like India, China, Russia, Poland etc. to cover a significant market share and consumer audience. Some of the major players in the global renal denervation devices market include ReCor Medical, Cordis, Terumo, Medtronic, Boston Scientific, St. Jude Medical, Cardiosonic Inc., Kona Medical, and Sound Intervention among others.

Market Segmentation

Market by Product Type

·         EnligHTN

·         Paradise renal denervation system

·         Simplicity renal denervation system

·         Vessix renal denervation system

·         Iberis renal sympathetic denervation system

·         Others

Market by Technology

·         Ultrasound

·         Radiofrequency

·         Micro-infusion

Market by Geography

·         North America

o   US

o   Canada

o   Mexico

·         Europe

o   UK

o   Germany

o   France

o   Rest of Europe

·         Asia-Pacific

o   China

o   Japan

o   India

o   Philippines

o   Rest of Asia-Pacific

·         Latin America

o    Brazil

o   Chile

o   Rest of Latin America

·         Middle East and Africa (MEA)

o   South Africa

o   Saudi Arabia

o   Rest of MEA

Cart Summary